Crux Wealth Advisors
Source: SEC Form 13F · as of Mar 2026Crux Wealth Advisors holds 11 biotech & pharma companies tracked by BioSniper, totaling $11.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$11.0M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 16,556 | $2.7M |
| NVSNovartis AG | 9,513 | $1.5M |
| IQVIQVIA Holdings Inc. | 8,300 | $1.4M |
| ELVElevance Health Inc. | 4,713 | $1.4M |
| MCKMcKesson Corporation | 1,328 | $1.1M |
| SNYSanofi | 19,194 | $925K |
| CORCencora Inc. | 2,116 | $665K |
| MRKMerck & Co., Inc. | 4,056 | $488K |
| JNJJOHNSON & JOHNSON | 1,568 | $383K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 820 | $222K |
| ARDXARDELYX, INC. | 35,812 | $215K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.